ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

BSA, BSC Approve Concept for NCI Scholars Program

March 7, 1997

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

NIH grant success rate drops to under 20 percent after 2011 budget cuts

May 13, 2011

In Brief: NCI Deputy Director Ihde To Leave Institute; Bynum To Retire; Lewis Thomas Dead At 80

December 10, 1993

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

Lymphedema Education Helps Reduce Symptoms, Study Finds

August 28, 2009